Genetic Analysis of Osteoblast Activity Identifies Zbtb40 as a Regulator of Osteoblast Activity and Bone Mass
Autor: | Dana A. Godfrey, Charles R. Farber, Gina M. Calabrese, Cheryl L. Ackert-Bicknell, Larry D. Mesner, Robert D. Maynard, Madison L. Doolittle |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
Male
Cancer Research Critical Care and Emergency Medicine Osteoporosis Genome-wide association study Alizarin Staining QH426-470 Mice 0302 clinical medicine Animal Cells Bone Density Osteogenesis Wnt4 Protein Medicine and Health Sciences Group-Specific Staining Connective Tissue Diseases Genetics (clinical) Trauma Medicine Cells Cultured Connective Tissue Cells Staining Bone mineral 0303 health sciences Gene knockdown Cell Differentiation Osteoblast Animal Models Genomics Phenotype Osteoblast Differentiation DNA-Binding Proteins medicine.anatomical_structure Experimental Organism Systems Connective Tissue Bone Fracture Female Cellular Types Anatomy Traumatic Injury Research Article musculoskeletal diseases medicine.medical_specialty Single-nucleotide polymorphism Mouse Models Locus (genetics) Biology Research and Analysis Methods 03 medical and health sciences Model Organisms Rheumatology Internal medicine Genome-Wide Association Studies Genetics medicine Animals Molecular Biology Gene Ecology Evolution Behavior and Systematics 030304 developmental biology Genetic association Osteoblasts Biology and Life Sciences Computational Biology Human Genetics Bone fracture Cell Biology Genome Analysis medicine.disease Mice Inbred C57BL Biological Tissue Endocrinology Genetic Loci Specimen Preparation and Treatment Animal Studies 030217 neurology & neurosurgery Developmental Biology |
Zdroj: | PLoS Genetics, Vol 16, Iss 6, p e1008805 (2020) PLoS Genetics |
DOI: | 10.1101/828525 |
Popis: | Osteoporosis is a genetic disease characterized by progressive reductions in bone mineral density (BMD) leading to an increased risk of fracture. Over the last decade, genome-wide association studies (GWASs) have identified over 1000 associations for BMD. However, as a phenotype BMD is challenging as bone is a multicellular tissue affected by both local and systemic physiology. Here, we focused on a single component of BMD, osteoblast-mediated bone formation in mice, and identified associations influencing osteoblast activity on mouse Chromosomes (Chrs) 1, 4, and 17. The locus on Chr. 4 was in an intergenic region between Wnt4 and Zbtb40, homologous to a locus for BMD in humans. We tested both Wnt4 and Zbtb40 for a role in osteoblast activity and BMD. Knockdown of Zbtb40, but not Wnt4, in osteoblasts drastically reduced mineralization. Additionally, loss-of-function mouse models for both genes exhibited reduced BMD. Our results highlight that investigating the genetic basis of in vitro osteoblast mineralization can be used to identify genes impacting bone formation and BMD. Author summary Osteoporosis is a common disease strongly influenced by genetics. Bone mineral density (BMD) is used clinically to predict fracture risk and has been used as a phenotype to identify genetic loci and genes impacting bone physiology. However, BMD is a complicated phenotype, impacted by a myriad of environmental factors and by two tissue-level processes: bone resorption and formation. We conducted a genome wide association study (GWAS) using the ability of the osteoblast to make bone-like mineralized nodules in vitro as a simpler phenotype to find genes that have a robust impact on bone. We identified Zbtb40 as a previously unappreciated regulator of osteoblast function and as a likely candidate gene for a genomic locus we identified for mineralized nodule formation on mouse Chromosome 4. This locus was one of the first identified for BMD in mice and is homologous for a GWAS locus on human Chromosome 1 for BMD. Further, we determined that Wnt4 may be a candidate gene for the mouse BMD locus, but is less likely to be a candidate for the osteoblast function locus. These data suggest that Zbtb40 may represent a novel target for future osteoporosis therapeutics that are anabolic for bone. |
Databáze: | OpenAIRE |
Externí odkaz: |